An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis

Genes Chromosomes and Cancer

Volumn 27, Issue 2, 2000, Pages 143-152

  Spieker, Nicole ^a   Beitsma, Mabel ^a   Van Sluis, Peter ^a   Roobeek, Ilja ^a   Den Dunnen, Johan T ^b   Speleman, Frank ^c   Caron, Huib ^a   Versteeg, Rogier ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 1; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DELETION; GENE ISOLATION; GENE LOCUS; GENE MAPPING; HUMAN; HUMAN CELL; NEUROBLASTOMA; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BACTERIOPHAGE P1; CHROMOSOMES, HUMAN, PAIR 1; CONTIG MAPPING; ELECTROPHORESIS, GEL, PULSED-FIELD; EXPRESSED SEQUENCE TAGS; GENE AMPLIFICATION; GENES; GENES, MYC; GENETIC MARKERS; GENETIC VECTORS; HUMANS; HYBRID CELLS; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; PHYSICAL CHROMOSOME MAPPING; TUMOR CELLS, CULTURED;

EID: 0033988769     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200002)27:2<143::AID-GCC5>3.0.CO;2-E     Document Type: Article

References (49)

1. Albertsen HM, Abderrahim H, Cann HM, Dausset JM, LePaslier D, Cohen D. 1990. Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc Natl Acad Sci USA 87:4256-4260.
2. Bellaiche Y, The I, Perrimon N. 1998. Tout-velu is a Drosophila homologue of the putative tumor suppressor EXT1 and is needed for Hh diffusion. Nature 394:85-88.
3. Benson DA, Boguski MS, Lipman DJ, Ostell J, Ouellette BF. 1998. Genbank. Nucl Acids Res 26:1-7.
4. Bitter MA, Le Beau MM, Rowley JD, Larson RA, Golomb HM, Vardiman JW. 1987. Association between morphology, karyotype and clinical features in mycloid leukaemias. Hum Pathol 18:211.
5. Brodeur GM, Sekhon GS, Goldstein MN. 1977. Chromosomal aberrations in human neuroblastomas. Cancer 40:2256-2263.
6. Brodeur GM, Seeger RC. Schwab M. Varmus HE. Bishop JM. 1984. Amplification of MYCN in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124.
7. Caron H, Van Sluis P, Van Roy N, De Kraker J, Speleman F, Voûte PA, Westerveld A, Slater R, Versteeg R. 1994. Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 55:341-347.
8. Caron H, Peter M, Van Sluis P, Speleman F, De Kraker J, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Versteeg, R. 1995. Evidence for 2 tumor suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with MYCN amplification. Hum Mol Genet 4:535-539.
9. Caron H, Van Sluis P, De Kraker J, Bokkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voute PA, Versteeg R. 1996. Allelic loss of chromosome 1p as a predictor of unfavourable outcome in patients with neuroblastoma. N Engl J Med 334:225-230.
10. Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R. 1995. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with MYCN amplification. Oncogene 10:291-297.
11. Chérif-Zahar B, Bloy C, Le Van Kim C, Blanchard D, Bailly P, Hermand P, Salmon C, Carton JP, Colin Y. 1990. Molecular cloning and protein structure of a human blood group RH polypeptide. Proc Natl Acad Sci USA 87:6243-6247.
12. Chumakov IM, Rigault P, Le Gall I, Cohen D. 1995. A YAC contig map of the human genome. Nature 377(Suppl):174-297.
13. Cox DR, Burmeister M, Price ER, Kim S, Meyers RM. 1990. Radiation hybrid mapping: a somatic cell genetic method for constructing high resolution maps of mammalian chromosomes. Science 250:245-250.
14. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE, Kefford RF. 1989. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86:4614-4618.
15. Francis F, Zehetner G, Hoglund M, Lehrach H. 1994. Construction and preliminary analysis of the ICRF human P1 library. Genet Anal Tech Appl 11:148-157.
16. Gergen JP, Wieschaus EF. 1986. The localized requirements for a gene affecting segmentation in Drosophila: analysis of larvea mosaic for runt. Dev Biol 109:321-335.
17. Gilbert F, Balaban G, Moorhead P, Bianchi D, Schlesinger H. 1982. Abnormalities of chromosome 1p in human neuroblastoma and cell lines. Cancer Genet Cytogenet 7:33-42.
18. Goldstein AM, Dracopoli NC, Ho EC, Fraser MC, Kearns KS, Bale SJ, McBride OW, Clark WJ, Jr, Tucker MA. 1993. Further evidence for a locus for cutaneous malignant melenoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am J Hum Genet 52:537-550.
19. Hudson T, Stein L, Gerety S, Ma J, Castle A, Silva J, Slonim D, Baptista R, Kruglyak L, Xu S, Hu X, Colbert A, Rosenberg C, Reeve-Daly MP, Rozen S, Hui L, Wu X, Vestergaard C, Wilson K, Bae J, Mailtra S, Ganiatsas S, Evans C, DeAngelis M, Ingalls K, Nahf R, Horton L, Oskin M, Collymore A, Ye W, Kouyoumjian V, Zernsteva I, Tarn J, Devine R, Courtney D, Renaud M, Nguyen H, O'Connor T, Fizames C, Faure S, Gyapay G, Dib C, Morisette J, Orlin J, Birren B, Goodman N; Weissenbach J, Hawkins T, Foote S, Page D, Lander E. 1995. An STS-based map of the human genome. Science 270:1945-1954.
20. Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Shizuya H, Chen C, Batzer MA, De Jong PJ. 1994. A new bacteriophage P1 derived vector for the propagation of large human DNA fragments Nat Genet 6:84-89.
21. Landsman D, Soares N, Gonzales FJ, Bustin M. 1986. Chromosomal protein HMG-17: complete human cDNA sequence and evidence for a multigene family. J Biol Chem 261:7479-7484.
22. Larsson N, Melander H, Marklund U, Osterman O, Gullberg M. 1995. G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems. J Biol Chem 270:14175-14183.
23. Lennon GG, Auffray C, Polymeropoulos M, Soares MB. 1996. The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics 33:151-152.
24. Le Van Kim C, Mouro I, Cherif-Zahar B, Raynal V, Cherrier C, Cartron JP, Colin Y. 1992. Molecular cloning and primary structure of the human blood group RHD polypeptide. Proc Natl Acad Sci USA 89:10925-10929.
25. Lifton RP, Sardet C, Poussegur J, Lalouel JM. 1990. Cloning of the human genomic amiloride-sensitive Na+/H+ antiporter gen, identification of genetic polymorphism, and localization on the genetic map of chromosome 1p. Genomics 7:131-135.
26. Martinsson T, Sjöberg RM, Hedborg F, Rogner P. 1995. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55:5681-5686.
27. Melhelm RF, Zhu XX, Hailat N, Strahler JR, Hanash SM. 1991. Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukaemia. J Biol Chem 266:17747-17753.
28. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko V, Ohki M. 1991. t(8,21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Nat Acad Sci USA 88:10431-10434.
29. Mouro I, Colin Y, Cherif-Zahar B, Cartron JP Le Van Kim C. 1993. Molecular genetic basis of the human Rhesus blood group system. Nat Genet 5:62-65.
30. Munn KE, Walker RA, Varley JM. 1995. Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene 10:1653-1657.
31. Nagai H, Negrini M, Carter SL, Gillum DR, Rosenberg AL, Schwanz GF, Groce CM. 1995. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res 55:1752-1757.
32. Nishizawa M, Semba K, Yoshida MC, Yamamoto T, Sasaki M, Toyoshima K. 1986. Structure, expression, and chromosomal location of the human c-FGR gene. Mol Cell Biol 6:511-517.
33. Praml C, Finke LH, Herfarth C, Schlag P, Schwab M, Amler L. 1995. Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 11:1357-1362.
34. Rubie H, Delattre O, Hartmann O, Combaret V, Michon J, Benard J, Peyroulet MC, Plantaz D, Coze C, Chastagner P, Baranzelli MC, Frappaz D, Lemerle J, Sommolet D. 1997. Loss of chromosome 1p may have a prognostic value in localised ncuroblastoma: results of the French NBL 90 study. Eur J Cancer 12:1917-1922.
35. Sartor O, Moriuchi R, Sameshima JH, Severino M, Gutkind JS, Robbins KC. 1992. Diverse biologic properties imparted by the c-FGR proto-oncogene. J Biol Chem 267:3460-3465.
36. Savelyeva L, Corvi R, Schwab M. 1994. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 55:334-340.
37. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur GM, Goldstein M, Trent JM. 1983. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 305:245-248.
38. Schwab M, Fllison J, Busch M, Rosenau W, Varmus HE, Bishop JM, 1984. Enhanced expression of the human gene MYCN consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 81:4940-4944.
39. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. 1985. Association of multiple copies of the MYCN oncogene with rapid progression of neurohlastomas. N Fngl J Med 313:1111-1116.
40. Van Roy N, Laureys G, Versteeg R, Opdenakker G, Speleman F. 1993. High resolution fluorescence mapping of 46 DNA markers to the short arm of chromosome 1. Genomics 18:71-78.
41. Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F. 1994. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 10:103-114.
42. Van Roy N, Cheng NC, Laureys G, Opdenakker G, Versteeg R, Speleman F. 1995. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma. Eur J Cancer 31A:530-535.
43. Versteeg R, Caron H, Cheng NC, Van der Drift P, Slater R, Westerveld A, Voute PA, Delattre O, Laureys G, Van Roy N, Speleman F. 1995. 1p36: every subband a suppressor? Eur J Cancer 31A:538-541.
44. Walter MA, Spillett DJ, Thomas P, Weissenbach J, Goodfellow PN. 1994. A method for constructing radiation hybrid maps of whole genomes. Nat Genet 7:22-28.
45. Weith A, Martinsson T, Cziepluch C, Bruderlein S, Amler LC, Berthold F, Schwab M. 1989. Neuroblastoma consensus deletion maps to 1p36.12. Genes Chromosomes Cancer 7:102-108.
46. Wijmenga C, Speck NA, Dracopoli NC, Hofker MH, Lin P, Collins FS. 1995. Identification of a new murine runt domain-containing gene, CBFA3, and localization of the human homologue, CBFA3, to chromosome 1p35-pter. Genomics 26:611-614.
47. Wise CA, Clines GA, Massa H, Trask BJ, Lovett M. 1997. Identification and localization of the gene for AUSTL, a third member of the multiple exostoses gene family. Genome Res 7:10-16.
48. Wuyts W, Van Hul W, De Boulle K, Bakker E, Vanhoenacker F, Mollica F, Ludecke HJ, Sayli BS, Pazzaglia UE, Mortier G, Hamel B, Conrad EU, Matsushita M, Raskind WH, Willems PJ. 1998. Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am J Hum Genet 62:346-354.
49. Zehetner G, Lehrach H. 1994. The reference library system: sharing biological material and experimental data. Nature 367:489-491.